37 / 64
241
Bibliografía
1.- Travis W, Costabel U, Hansell D, King T,
Lynch D, Nicholson A, et al. An official Ame-
rican Thoracic Society/European Respiratory Society
statement: Update of the international multidisciplinary
classification of the idiopathic interstitial pneumonias.
Am J Respir Crit Care Med 2013; 188: 733-48.
2.- Baumgartner K, Samet J, StidleyC, Colby
T, Waldron J. Cigarette smoking: a risk factor for
idiopathic pulmonary fibrosis. Am J Respir Crit Care
Med 1997; 155: 242-8.
3.- Wells A, NicholsonA, Hansell D. Challenges
in pulmonary fibrosis: smoking-induced diffuse intersti-
tial lung diseases. Thorax 2007; 62: 904-10.
4.- Franks T, Galvin J. Smoking-Related “Interstitial”
Lung Disease. Arch Pathol Lab Med 2015; 139: 974-7
5.- Morlá M, Busquets X, Pons J, Sauleda
J, MacNee W, Agustí A. Telomere shortening in
smokers with and without COPD. Eur Respir J 2006;
27: 525-8.
6.- PatelA, Lin L, GeyerA, Haspel J, An C, Cao J,
et al. Autophagy in idiopathic pulmonary fibrosis. PLoS
ONE 2012; 7: e41394.
7.- Margaritopoulos G, Harari S, Caminati A,
Antoniou K. Smoking-related idiopathic interstitial
pneumonia: A review. Respirology 2016; 21: 57-64.
8.- Roden A, Yi E. Pulmonary Langerhans Cell Histio-
cytosis: An update from the Pathologists’ Perspective.
Arch Pathol Lab Med 2016; 140: 230-40.
9.- Elia D, Torre O, Cassandro R, Caminati A,
Harari S. Pulmonary Langerhans cell histiocytosis:
a comprehensive analysis of 40 patients and literature
review. Eur J Int Med 2015; 26: 351-6.
10.- Gaensler E, Carrington C. Open biopsy for
chronic diffuse infiltrative lung disease: clinical, roent-
genographic, and physiological correlations in 502
patients. Ann Thorac Surg 1980, 30: 411-26.
11.- Vassallo R, Ryu J, Colby T, Hartman T,
Limper AH. Pulmonary Langerhans’-cell histiocyto-
sis. N Engl J Med 2000; 342: 1969-78.
12.- Mason R, Foley N, Branley H, Adamali H,
Hetzel M, Maher T, et al. Pulmonary Langerhans
cell histiocytosis (PLCH): a new UK register. Thorax
2014; 69: 766-7.
13.- Suri H, Yi E, Nowakowski G, Vassallo R.
Pulmonary langerhans cell histiocytosis. Orphanet J
Rare Dis 2012; 7: 16.
14.- Vassallo R, Ryu J, Schroeder D, Decker P,
Limper A. Clinical outcomes of pulmonary Langer-
hans’ cell histiocytosis in adults. N Engl J Med 2002;
346: 484-90.
15.- Dauriat G, MalH, Thabut G, Mornex J, Ber-
tocchi M, Tronc F, et al. Lung transplantation for
pulmonary Langerhans’ cell histiocytosis: a multicenter
analysis. Transplantation 2006; 81: 746-50.
16.- Fartoukh M, Humbert M, Capron F, Maître
S, Parent F, Le Gall C, et al. Severe pulmonary
hypertension in histiocytosis X. Am J Respir Crit Care
Med 2000; 161: 216-23.
17.- Baqir M, Vassallo R, Maldonado F, Yi E,
Ryu J. Utility of bronchoscopy in pulmonary. Lan-
gerhans cell histiocytosis. J Bronchol Interv Pulmonol
2013; 20: 309-12.
18.- Lorillon G, BergeronA, Detourmignies L,
Jouneau S, Wallaert B, Frija J, et al. Cladribi-
ne is effective against cystic pulmonary Langerhans cell
histiocytosis. Am J Respir Crit Care Med 2012; 186:
930-2.
19.- Caminati A, Graziano P, Sverzellati N,
Harari S. Smoking-related interstitial lung diseases.
Pathologica 2010; 102: 525-36.
20.- Ryu J, Myers J, Capizzi S, DouglasW, Vassa-
llo R, Decker P. Desquamative interstitial pneumo-
nia and respiratory bronchiolitis-associated interstitial
lung disease. Chest 2005; 127: 178-84.
21.- Portnoy J, Veraldi K, Schwarz M, Cool C,
Curran-Everett D, Cherniack R, et al. Res-
piratory bronchiolitis-interstitial lung disease: long-term
outcome. Chest 2007; 131: 664-71.
22.- Hagmeyer L, Randerath W. Smoking-related
interstitial lung disease. Dtsch Arztebl Int 2015; 112:
43-50.
23.- Woo O, Yong H, Oh Y, Lee S, Kim H, Kang E.
Respiratory bronchiolitis-associated interstitial lung
disease in a nonsmoker: radiologic and pathologic fin-
dings. AJR 2007; 188: 412-4.
24.- SieminskaA, Kuziemski K. Respiratory bronchio-
litis-interstitial lung disease. Orphanet J Rare Dis 2014;
9:106.
25.- Attili A, Kazerooni E, Gross B, FlahertyK,
Myers J, Martínez F. Smoking-related interstitial
lung disease: radiologic-clinical-pathologic correlation.
Radiographics 2008; 28: 1383-96.
26.- Hansell D, NicholsonA. Smoking-related diffu-
se parenchymal lung disease: HRCT-pathologic correla-
tion. Semin Respir Crit Care Med 2003; 24: 377-92.
27.- Caminati A, Graziano P, Sverzellati N,
Harari S. Smoking-related interstitial lung diseases.
Pathologica 2010; 102: 525-36.
28.- Park J, Brown K, Tuder R, Hale V, King T,
Lynch D. Respiratory bronchiolitis-associated inters-
titial lung disease: radiologic features with clinical and
pathologic correlation. J Comput Assist Tomogr 2002;
26: 13-20.
29.- Tazelaar H, Wright J, ChurgA. Desquamative
interstitial pneumonia. Histopathology 2011; 58: 509-
16.
30.- Caminati A, Cavazza A, Sverzellati N,
Harari S. An integrated approach in diagnosis of
smoking-related interstitial lung diseases. Eur Respir
Rev 2012; 21: 207-17.
Enfermedades pulmonares difusas relacionadas al tabaco
Rev Chil Enferm Respir 2016; 32: 233-243